arrow
G

Giorgia Bodini

university of genoa
H指数:35
被引数:3,804

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-World Effectiveness and Safety of Upadacitinib in Patients With Crohn's Disease—A Multicentre Prospective Study From the Italian Group for the Study of Inflammatory Bowel Diseases (IG-IBD)

真实世界中乌帕替尼在克罗恩病患者中的有效性和安全性——一项来自意大利炎症性肠病研究组(IG-IBD)的多中心前瞻性研究

2026-09-110
PRE
An inverse probability of treatment weighted comparison between vedolizumab, ustekinumab, and tofacitinib in anti-TNF-experienced ulcerative colitis patients

对经验性抗-TNF溃疡性结肠炎患者中 vedolizumab、ustekinumab 和 tofacitinib 的逆概率治疗加权比较

2026-06-150
PRE
Comparative Effectiveness and Safety of Tofacitinib, Filgotinib, and Upadacitinib in Ulcerative Colitis: A Multicenter Real-World Cohort Study

托法替布、菲洛吉替尼和乌帕替尼治疗溃疡性结肠炎的疗效和安全性比较:一项多中心真实世界队列研究

2026-05-090
OAAI
Concomitant 5-Aminosalicylic Acid Does Not Affect the Efficacy of Janus Kinase Inhibitors in Ulcerative Colitis

同时使用的5-氨基水杨酸不影响溃疡性结肠炎中JAK抑制剂的疗效

2026-03-050
OAAI
Upadacitinib’s Effectiveness and Safety as a Second- or Third-Line Therapy in Patients with Ulcerative Colitis: Data from a Real-World Study

乌帕替尼作为溃疡性结肠炎患者二线或三线治疗的有效性与安全性:真实世界研究数据

2025-11-030
OAAI
Filgotinib effectiveness and safety as second or third-line therapy in patients with ulcerative colitis: data from a real-world study

Tursi, A.; Mocci, G.; Costa, F.; Ceccarelli, L.; Savarino, E.; De Barba, C.; Mucherino, C.; D’antonio, E.; Montesano, L.; Marzo, M.; 等. Filgotinib 在溃疡性结肠炎患者中作为二线或三线治疗的有效性与安全性:真实世界研究数据. Intest. Res. 2025, 已接收. [CrossRef] [PubMed]

2025-09-011
PRE
Vedolizumab in inflammatory bowel disease: Real-world outcomes and their prediction with machine learning—the IG-IBD LIVE study

Vedolizumab在炎症性肠病中的真实世界结局及其机器学习预测——IG-IBD LIVE研究

2025-05-120
PRE
P0634 Upadacitinib Effectiveness And Safety In Patients With Ulcerative Colitis: Data From A Real-World Study
2025-01-220
PRE
Filgotinib effectiveness and safety as second or third-line therapy in patients with ulcerative colitis: data from a real-world study
2025-01-220
PRE
Long-Term Effectiveness and Safety of Ustekinumab in Crohn's Disease: Results from a Large Real-Life Cohort Study
2024-11-271
OAAI
Follow-up evaluation and management of anemia in inflammatory bowel disease: A study by the Italian Group for Inflammatory Bowel Diseases (IG-IBD)
2024-09-012
PRE